Autonomix Medical, Inc. (NASDAQ:AMIX) has reported a substantial decrease in short interest for the month of December. As of December 15, 2023, short interest stood at 133,864 shares, reflecting a significant decline of 62.1% from the November 30, 2023 total of 353,480 shares. Currently, this represents approximately 2.1% of the company’s total shares being short sold.
The reduced short interest indicates a shift in investor sentiment towards the company. With an average daily trading volume of 221,552 shares, the days-to-cover ratio is now at 0.6 days, suggesting that the short positions could be covered relatively quickly if necessary.
Current Stock Performance and Financial Overview
On December 15, the shares of Autonomix Medical opened at $0.58. The company has witnessed a year marked by volatility, with a 1-year low of $0.56 and a high of $4.58. The stock is currently trading below its 50-day simple moving average of $0.88 and its 200-day average of $1.12.
Autonomix Medical has a market capitalization of approximately $3.98 million, with a price-to-earnings ratio of -0.12. The company’s financial performance has raised some concerns among analysts, particularly after reporting an earnings per share (EPS) of ($1.38) for the latest quarter, which met the analysts’ consensus expectations. Looking ahead, analysts predict that Autonomix Medical will post an EPS of -10 for the current year.
About Autonomix Medical
Founded in 2014 and headquartered in The Woodlands, Texas, Autonomix Medical, Inc. is a development-stage medical device company. Its focus is on advancing technologies aimed at sensing and treating disorders associated with the peripheral nervous system. The company’s innovative technology includes a catheter-based microchip-enabled sensing array designed to detect and differentiate peripheral neural signals.
As Autonomix Medical continues to navigate the complexities of the medical device market, the recent drop in short interest may reflect a renewed confidence among investors. The company remains committed to developing its pioneering technologies, with the potential to make a significant impact in its field.
For those interested in staying updated on Autonomix Medical’s developments, the company offers a daily newsletter that summarizes the latest news and analyst ratings.
